FDA NDC Directory · JSON-LD · Markdown

belumosudil

NDC 12522-3310 · DRUG FOR FURTHER PROCESSING · TABLET

Labeler / ManufacturerSanofi S.r.l.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeTABLET
Active ingredientsBELUMOSUDIL (200 mg/1)
Marketing started20260819
Package count1

External sources

Source: openFDA. Public-domain (CC0).